These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 27253830)
1. Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents. Eissa IH; El-Naggar AM; El-Hashash MA Bioorg Chem; 2016 Aug; 67():43-56. PubMed ID: 27253830 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives. Metwally NH; Deeb EA Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077 [TBL] [Abstract][Full Text] [Related]
3. 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation. Zhai M; Liu S; Gao M; Wang L; Sun J; Du J; Guan Q; Bao K; Zuo D; Wu Y; Zhang W Eur J Med Chem; 2019 Apr; 168():426-435. PubMed ID: 30831410 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives. Bakr RB; Mehany ABM; Abdellatif KRA Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives. Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633 [TBL] [Abstract][Full Text] [Related]
6. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity. Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, antimicrobial, antiquorum-sensing and antitumor evaluation of new series of pyrazolopyridine derivatives. El-Gohary NS; Shaaban MI Eur J Med Chem; 2018 Sep; 157():729-742. PubMed ID: 30138804 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues. Jian XE; Yang F; Jiang CS; You WW; Zhao PL Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and cytotoxicity studies of novel pyrazolo[1, 5-a]pyridine derivatives. Ravi C; Qayum A; Chandra Mohan D; Singh SK; Adimurthy S Eur J Med Chem; 2017 Jan; 126():277-285. PubMed ID: 27889631 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies. El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular modeling and biological evaluation of new pyrazolo[3,4-b]pyridine analogs as potential antimicrobial, antiquorum-sensing and anticancer agents. El-Gohary NS; Gabr MT; Shaaban MI Bioorg Chem; 2019 Aug; 89():102976. PubMed ID: 31103494 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents. Chavva K; Pillalamarri S; Banda V; Gautham S; Gaddamedi J; Yedla P; Kumar CG; Banda N Bioorg Med Chem Lett; 2013 Nov; 23(21):5893-5. PubMed ID: 24060486 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
15. One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents. Barghash RF; Eldehna WM; Kovalová M; Vojáčková V; Kryštof V; Abdel-Aziz HA Eur J Med Chem; 2022 Jan; 227():113952. PubMed ID: 34731763 [TBL] [Abstract][Full Text] [Related]
16. Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II Inhibitors. Eissa IH; El-Naggar AM; El-Sattar NEAA; Youssef ASA Anticancer Agents Med Chem; 2018; 18(2):195-209. PubMed ID: 28699490 [TBL] [Abstract][Full Text] [Related]
17. 3-Aminopyrazolo[3,4-b]pyridine: Effective Precursor for Barium Hydroxide-Mediated Three Components Synthesis of New Mono- and Bis(pyrimidines) with Potential Cytotoxic Activity. Sanad SMH; Mekky AEM Chem Biodivers; 2022 Jan; 19(1):e202100500. PubMed ID: 34784450 [TBL] [Abstract][Full Text] [Related]